Medical Education
Board Certification
Graduate Clinical and Research Work Experience
Internships and Residencies
Medical School Honors
Memberships
Grants and Awards
Bibliography
Book Chapters
Presentations
Abstracts
MEDICAL EDUCATION:
M.D., 1985-1990
Christian Medical College, Vellore Madras University, India
Top of page
BOARD CERTIFICATION:
American Board of Thoracic Surgery, 2004
American Board of Surgery, 2001
ECFMG Certification, 1993
Top of page
GRADUATE CLINICAL AND RESEARCH WORK EXPERIENCE:
2001-2002
Chief Resident, Division of Cardiothoracic Surgery
Columbia University, New York, NY
2000-2001
Fellow, Division of Cardiothoracic Surgery
Columbia University, New York, NY
1999-2000
Chief Resident, Department of Surgery
New York Medical College, Bronx, NY
1993-1994
Research Fellow, Division of Cardiothoracic Surgery
Columbia University, New York, NY
1993-1994
Research Fellow, Division of Cardiothoracic Surgery
University of Minnesota, Minneapolis, MN
Top of page
INTERNSHIP AND RESIDENCIES:
1994-1999
Residency in General Surgery, Department of Surgery
New York Medical College, Bronx, NY
1990-1991
Internship (Rotating)
Christian Medical College Hospital, Vellore, India
Top of page
MEDICAL SCHOOL HONORS:
Finalist, Paul Samson Resident Competition, Western Thoracic Surgical Society, 2001.
Young Investigator Award, American Society of Transplant Surgeons, 1999.
N.D. Jeyasekaran Prize - Best Outgoing Clinical Student, 1989-90.
First Rank in II M.B.B.S - Anil George Memorial Prize, 1989.
First Rank in Final M.B.B.S., 1989.
John S. Carman Prize in Surgery, 1989.
Somervell Prize in Clinical Surgery, 1989.
Victor C. Rambo Prize in Ophthalmology, 1988.
Mary Israel Prize in Medicine, 1989.
Carol Jameson Prize in Obstetrics & Gynecology, 1989.
Dhanajay Abhyanker Prize in Physiology: Regulation of Coronary Blood Flow, 1986.
Edward Gault Prize in Pathology: Pathology of the Pancreas in Diabetes Mellitus, 1986.
Top of page
MEMBERSHIPS:
International Society of Heart and Lung Transplantation
Candidate, American College of Surgeons
Council on Cardiovascular Surgery, American Heart Association
American Society of Artificial Internal Organs
New York Society for Thoracic Surgery
Surgical Society of New York Medical College
New York Academy of Sciences
Top of page
GRANTS AND AWARDS:
1. Development of An Intrathoracic Pulmonary Assist Device in an Ovine Model: Awarded by the Department of Surgery, Columbia University, 1997.
2. Young Investigator Award 1999, American Society of Transplant Surgeons.
3. Inhibition of Phospholipase A2 Prevents Ischemia Reperfusion Injury in a Rat Cardiac Transplant Model. Awarded by the Department of Surgery, Columbia University, 2000.
4. Finalist, Paul Samson Resident Competition, Western Thoracic Surgical Society 2001.
5. Co-Principal Investigator: The effect of autologous bone-marrow derived angioblasts after coronary artery bypass (CABG) surgery in patients with myocardial infarction.
6. Reviewer for Annals of Thoracic Surgery (2000- present).
Top of page
BIBLIOGRAPHY:
1. John R, Mathai D, Daniel AJ, Lalitha MK: Bilateral septic arthritis due to S. enteritidis. Diagnostic Microbiology and Infectious Diseases 1993; 17(2): 167-9.
2. Sadhu D, Moses BV, John R, Lalitha MK: Hydatid disease of the liver complicated by salmonellosis. Transactions of the Royal Society of Tropical Medicine and Hygiene 1993; 87: 674-5.
3. John R, Korula RJ, Lal N, Shukla V, Lalitha MK: Salmonellosis complicating aortic aneurysms. International Angiology 1994; 13: 177-80.
4. Lalitha MK, John R: Unusual manifestations of salmonellosis - a surgical problem. Quarterly Journal of Medicine 1994; 87: 301-9.
5. John R, Wangensteen OD, Andrade R, Shumway SJ: The parabiotic model for the assessment of lung preservation - potential problems and solutions. Acta Bio-Medica (Parmense) 1994; 65: 75-81.
6. Leventhal JR, John R, Fryer JP, Witson JC, Derlich JM, Remiszewski J, Dalmasso AP, Matas AJ, Bolman RM III: Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption. Transplantation 1995; 59: 294-300.
7. Kroshus TJ, Dalmasso AP, Leventhal JR, John R, Matas AJ, Bolman RM: Antibody removal by column immunoabsorption prevents injury in an ex vivo model of pig to human xenograft hyperacute rejection. Journal of Surgical Research 1995; 59: 43-50.
8. Kroshus TJ, Kshettry V, Savik K, John R, Hertz MI, Bolman RM: Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. Journal of Thoracic and Cardiovascular Surgery 1997; 114: 195-202.
9. John R, Zittsman JL: Pitfalls in diagnostic laparoscopic evaluation of the contralateral groin. Journal of Pediatric Endosurgery and Innovative Techniques.1998; 2:55-9.
10. Kwiatkowski P, Artrip JH, Ankersmit J, John R, Wang SF, Ma N, Michler RE, Itescu S: Importance of CD49d-VCAM interactions in human monocytes adhesion to porcine endothelium. Xenotransplantation 1998;5:67-74.
11. John R, Choudhri AF, Ting W, Smith CR, EA Rose, Oz MC: Role of cardiopulmonary bypass in single vessel coronary revascularization: Implications for MID-CABG. Heart Surg Forum 1998 1(1):65-70.
12. John R, Verghese JJ, Rao P, Agarwal N, Cayten GC. Is routine biliary tract imaging necessary in biliary pancreatitis? Surgical Endoscopy;1998;12:P241.
13. Ivatury RR, Porter JM, Simon RJ, Islam S, John R, Stahl WM. Intra-abdominal hypertension after life-threatening penetrating abdominal hypertension: Prophylaxis, incidence and clinical relevance to gastric mucosal pH and abdominal compartment syndrome. Journal of Trauma 1998;44:1016-1023.
14. John R, Kwiatkowski P, Choi S, Ankersmit J, Wang SF, Artrip JH, NM Edwards, S Itescu. Recognition of gal alpha 1,3 gal by human natural killer (NK) cells augments the B cell Ig anti-gal antibody response. Surgical Forum 1998; Vol XLIX: 385-7.
15. John R, Chen JC, Weinberg A, Oz MC, Mancini D, Itescu S, MG Galantowicz, Smith CR, Rose E, Edwards NM. Long term survival after cardiac retransplantation: A 20-year single center experience. Journal of Thoracic and Cardiovascular Surgery 1999;3: 675.
16. Kwiatkowski P, Artrip JH, John R, Wang SF, NM Edwards, Michler RE, Itescu S: Induction of swine major histocompatibility complex (MHC) class I molecules on porcine endothelium by tumor necrosis factor -alpha reduces lysis by human natural killer cells. Transplantation;1999:67:211-218.
17. John R, Lietz K, Burke E, J Ankersmit, D Mancini, N Suciu-Focca, N Edwards, E Rose, M Oz, S Itescu: Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation 1999:100:II 229-35.
18. JM Chen, S Culinane, TB Spanier, JH Artrip, R John, NM Edwards, MC Oz, DW Landry: Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999:100:II 244-6.
19. John R, AF Choudhri, AD Weinberg, W Ting, EA Rose, CR Smith, MC Oz: Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Annals of Thoracic Surgery 2000;69:30-6.
20. JA Ankersmit, NM Edwards, M Schuster, R John, A Kocher, EA Rose, MC Oz, S Itescu. Quantitative changes in T cell populations following left ventricular assist device implantation: Relationship to T cell apoptosis and soluble CD95. Circulation 1999:100:II 211-5.
21. NM Edwards, Rajasinghe HA, R John, JM Chen, S Itescu, D Mancini: Cardiac transplantation in over 1000 patients: A single institution experience from Columbia University. Clinical Transplants 1999;249-261.
22. John R, Beniaminowitz A, Artrip JA, Rabbani L, Michler RE: The diagnosis and management of aortic dissection occurring years after open heart surgery. The Journal of Cardiovascular Surgery 2000;41:251-3.
23. John R, Kwiatkowski P, Edwards N, Wang SF, Itescu S. Human natural killer cells augment B cell responses to porcine xenoantigens. Transplant Proceedings 2000;32(5):928.
24. John R, Rajasinghe HA, JM Chen, et al. Impact of current management practices on early and late mortality in over 500 consecutive heart transplant recipients. Annals of Surgery 2000;232:302-11.
25. John R, Rajasinghe HA, S Itescu, S Suratwalla, K Lietz, A Weinberg, A Kocher, D Mancini, R Drusin, M Oz, CR Smith, E Rose, NM Edwards: Factors affecting long term survival (>10 years) after cardiac transplantation in the cyclosporine era. Journal of American College of Cardiology.2001;37:189-94.
26. John R, Oz MC. Stroke after coronary artery bypass grafting: are we forgetting atrial fibrillation?:Reply. Annals of Thoracic Surgery 2001;71:401-2.
27. Lietz K, Beniaminovitz A, Burke E, John R, et al. Influence of donor-recipient HLA-DR matching on efficacy of anti-CD25 mab in cardiac transplantation. Transplantation Proceedings 2001;33:1018.
28. Lietz K, John R, Burke E, Kocher A, Schuster M, Suciu-Focca N, Mancini D, Edwards N, Itescu S. Increased risk for cardiac allograft rejection in recipients with HLA-B8, DR type Transplantation Proceedings 2001;33:481-482.
29. Schuster M, Ankersmit J, Kocher A, Lietz K, Schuster N, John R, Edwards N, Oz M, Itescu S. Induction of T cell apoptosis by polyurethane biomaterials used in left ventricular assist devices is dependant on calcineurin activation. Transplantation Proceedings 2001;33:1958-1959.
30. Schuster M, Kocher A, Lietz K, Ankersmit J, John R, Edwards N, Oz M, Itescu S. Induction of CD40 ligand in human T cells by biomaterials derived from left ventricular assist device surface. Transplantation Proceedings 2001;33:1960-1962.
31. Lietz K, John R, Burke E, Ankersmit J, McCue J, Mancini D, Naka Y, Oz M, Edwards N. Pre-transplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation 2001;72:277-83.
32. John R, Rajasinghe HA, Chen JM, Weinberg A, Sinha P, Mancini DM, Oz MC, Smith CR, Rose EA, Edwards NM. Long term outcomes following cardiac transplantation: An experience based on different eras of immunosuppression. Annals of Thoracic Surgery 2001;72:440-9.
33. Lietz K, John R, Kocher A, Schuster M, Mancini D, Edwards N, Itescu S. Female cardiac transplant recipients demonstrate increased prevalence of autoimmunity and greater risk for alloreactivity. Circulation 2001;104:I 177-83.
34. Itescu S, Lietz K, Burke E, John R, et al. Intravenous pulse therapy with cyclophosphamide reduces T cell alloreactivity and allograft rejection in highly sensitized cardiac transplant recipients. Circulation 2002; 105: 1214-1219.
35. Chen JM, Sinha P, Rajasinghe HA, Suratwala SJ, McCue JD, McCarty MJ, Caliste Z, Hauff H, John R, Edwards NM. Do donor characteristics really matter? Short- and long-term impact of donor characteristics on recipient survival, 1995-1999. J Heart Lung Transplant 2002;21:608-10.
36. Schuster M, Kocher A, John R, Lietz K, Edwards N, Oz M, Itescu S. B cell activation and allosensitization after left ventricular assist device implantation is due to T cell activation and CD40 ligand expression. Human Immunology 2002; 63:211-220.
37. Lietz K, John R, et al. IgM to IgG anti-HLA class II antibody switching in cardiac transplant recipients is associated with increased risk of cellular rejection and coronary artery disease and is prevented by mycophenolic acid. Transplant Proc 2002;34 (5):1828.
38. John R, Lietz K, Naka Y, Schuster M, Rao V, Mancini D, Rose E, Smith C, Oz M, Edwards N, S Itescu. Immunologic sensitization in recipients of left ventricular assist devices: J Thorac Cardiovasc Surg 2003; 125:578-91.
39. Lietz K, John R, Beniaminovitz A, Burke E, Mancini D, Edwards N, Itescu S. A randomized study of interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy. Transplantation 2003;75:781-7.
40. Itescu S, Schuster M, Burke E, Ankersmit J, Kocher A, Deng M,John R, Lietz K. Immunobiologic consequences of ventricular assist devices. Cardiology Clinics 2003;21:119-33.
41. Morgan J, John R, Weinberg A, Kherani A, et al. Prolonged donor ischemic time does not affect long-term survival in adults patients following cardiac transplantation. J Thorac Cardiovasc Surg (accepted).
42. Itescu S, John R. Interactions between the recipient immune system and the left ventricular assist device surface: Immunological and clinical implications. Annals of Thoracic Surgery 2003;75:S58-65.
43. Morgan J, John R, Weinberg A, et al. Heart transplantation in diabetic recipients: A decade review of 161 patients at Columbia Presbyterian. J Thorac Cardiovasc Surg 2004;127:1486-92.
44. Lietz K, John R, Mancini D, Edwards N. Outcomes in cardiac transplant recipients with allografts from older donors versus mortality on transplant waiting list: The implications for donor selection criteria. J American College of Cardiology (in press).
45. Morgan J, Morales D, John R, Ginsburg M, Kherani A, Vigilance D, Smith C, Oz M, Argenziano M. Endoscopic, Robotically Assisted Implantation of Phrenic Pacemakers. J Thoracic and Cardiovascular Surgery 2003; 126:582-3.
46. Morgan J, John R, Weinberg A, et al. Long-Term Results of Cardiac Transplantation in patients 65 Years of Age and Older: A Comparative Analysis. Annals of Thoracic Surgery 2003;76:1982-7.
47. John R, Morgan J, Park Y, Oz M, Naka Y. Is severe right ventricular failure in LVAD recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Annals of Thoracic Surgery 2004;77:859-863.
48. Morgan J, John R, Hollingsworth KW, et al. Stroke after cardiac transplantation in adults: prevalence, risk factors and outcome. Annals of Thoracic Surgery (accepted).
49. Morgan J, John R, Rao V, Weinberg A, et al. Bridging to transplant with the Heartmate left ventricular assist device: The Columbia Presbyterian twelve-year experience. J Thoracic and Cardiovascular Surgery 2004;127:1309-16.
50. John R, Naka Y. Invited Commentary: Clinical significance of P1A polymorphism of platelet llb/llla receptors during long-term VAD support. Annals of Thoracic Surgery 2004;77:874.
51. Morgan JA, John R, Mancini DM, Edwards NM. Should heart transplantation be considered as a treatment option for patients aged 70 years and older? J Thoracic and Cardiovascular Surgery 2004;127:1817-9.
52. John R. Donor selection and management for heart transplantation. Seminars in Thoracic and Cardiovascular Surgery 2004:16;364-9.
53. Morgan J, John R, Mosca R, et al. Successful outcome with extended allograft ischemic time in pediatric heart transplantation. J Heart and Lung Transplantation 2005:24;58-62.
Manuscripts submitted
1. Dang N, Topkara V, Leacche M, John R, Oz M, Byrne J, Naka Y. Left Ventricular assist device implantation following acute anterior wall myocardial infarction and cardiogenic shock: a two center study. Circulation (submitted).
Top of page
BOOK CHAPTERS:
1. John R, Artrip J, Michler RE: Genetically engineered organs. In Advances in Cardiac Surgery 1998;Vol 10: 229-239. Eds. Laks H, Karp R., Mosby.
2. John R, Kwiatkowski P, Michler RE: The present status and future impact of cardiac xenotransplantation. In Clinical Xenotransplantation. Eds. Ildstad S, Platt J, Groth C.
3. John R, Deng M, Itescu S. Current status of Immunosuppression for cardiac transplantation. In Cardiac Transplantation. Eds. Edwards N, Chen J 2003.
4. Deng MC, John R, Itescu N, Suciu-Foca N. Principles of transplant immunology. In Shane E. Transplantation and osteoporosis.
Top of page
PRESENTATIONS AT NATIONAL AND INTERNATIONAL MEETINGS:
1. John R, Hertz M, Savik K, Cahill B, Fox J, Reinsmoen N, Bolman RM: Multivariate analysis of risk factors for obliterative bronchiolitis in lung allograft recipients. International Society of Heart and Lung Transplantation, Venice, Italy, 1994.
2. John R, Leventhal JR, Fryer JP, Witson JC, Derlich JM, Remiszewski J, Dalmasso AP, Matas AJ, Bolman RM III: Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption: results and in vitro and in vivo studies. American Society of Transplant Surgeons, Chicago, 1994.
3. John R, Bolman RM, Kshettry V, Savik K, Hertz MI: Does age > 50 years have adverse outcomes on lung allograft recipients. International Society of Heart and Lung Transplantation, San Francisco, 1995.
4. John R, Burke E, Mancini D, et al. Intravenous immunoglobulin versus cyclophosphamide and plasmapheresis for reduction of anti-HLA antibodies in highly sensitized patients awaiting cardiac transplantation. International Society of Heart and Lung Transplantation, Chicago, 1998.
5. John R, Chen J, Weinberg A, Oz M, Itescu I, Rose E, Edwards N. A 20-year experience with cardiac retransplantation. American Association of Thoracic Surgery, Boston, 1998.
6. John R, Verghese JJ, Rao P, Agarwal N, Cayten GC. Is routine biliary tract imaging necessary in biliary pancreatitis? American College of Surgeons, Bronx Chapter meeting, 1998.
7. John R, Choudhri A, Weinberg A, Ting W, Rose E, Smith CR, Oz MC: A multivariate analysis of the risk factors for stroke after coronary artery bypass grafting. New YorkSociety of Thoracic Surgeons, New York, 1998.
8. John R, Kwiatkowski P, Choi S, Ankersmit J, Wang SF, Artrip JH, NM Edwards, S Itescu. Recognition of gal alpha 1,3 gal by human natural killer (NK) cells augments the B cell Ig anti-gal antibody response. Surgical Forum, American College of Surgeons, Orlando, 1998.
9. John R, Choudhri A, Weinberg A, et al. Defining high risk CABG patients at risk for stroke: a case for MIDCABG. American Heart Association, Dallas, 1998.
10. John R, Suratwalla S, Mancini D, Weinberg A, Itescu S, R Druzin, Rose EA, Edwards NM. Long-term survival (> 10 years) after cardiac transplantation in the cyclosporine era. American Heart Association, Dallas, 1998.
11. John R, Lietz K, Burke E, et al. Sucessful management of highly sensitized patients awaiting cardiac transplantation using intravenous immunoglobulin. American Heart Association, Dallas, 1998.
12. John R, Kwiatkowski P, Artrip JH, et al. Interactions between human natural killer cells and B cells cause augmentation of IgG humoral responses. American Heart Association, Dallas, 1998.
13. John R, Choudhri AF, Ting W, Weinberg AD, Smith CR, EA Rose, Oz MC: Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Society of Thoracic Surgeons, San Antonio, 1999.
14. John R, Kwiatkowski P, Artrip JH, et al. Interactions between human natural killer cells and B cells cause augmentation of IgG humoral responses. American Society of Transplant Surgeons, Chicago, 1999.
15. John R, Mandigo CE, Weinberg AD, et al. Survival after heart transplantation: are pretransplant risk factors important. American Society of Transplant Surgeons, Chicago, 1999.
16. John R, Rajasinghe HA, JM Chen, et al. Impact of current management practices on early and late mortality in 500 cardiac transplant recipients. American Surgical Association, Philadelphia, 2000.
17. John R. Advances in heart transplantation. Surgical Grand Rounds, Our Lady of Mercy Medical Center, New York, March 2000.
18. John R, Lietz K, Burke E, Schuster M, et al. Intravenous immunoglobin therapy in highly sensitized cardiac allograft recipients facilitates transplantation across donor specific IgG positive cross matches. International Society of Heart and Lung Transplantation, Vancouver 2001.
19. John R, Lietz K, Schuster M, Mancini D, et al. Older age is associated with reduced alloreactivity and graft rejection after cardiac transplantation. International Society of Heart and Lung Transplantation, Vancouver 2001.
20. John R, Itescu S, Naka Y, et al. Immunologic sensitization in recipients of left ventricular assist devices: Implications for cardiac allograft rejection and survival. Western Thoracic Surgical Association, San Diego 2001.
21. John R, Lietz K, Burke E, Schuster M, Mancini D, Edwards N, Itescu S. Outcomes of highly sensitized LVAD recipients transplanted across positive IgG cross matches. American Heart Association, Anaheim 2001.
22. John R. Current surgical therapy for heart failure. Surgical Grand Rounds, Our Lady of Mercy Medical Center, New York, October 2003.
23. John R. Duration of mechanical support in patients with end stage heart failure affects survival following cardiac transplantation. Society of Thoracic Surgeons, San Antonio, 2004.
24. John R. Surgical Options for Valve Disease. 5th Annual Lillehei Symposium, Minneapolis, MN, April 2004.
25. John R. Left Ventricular Assist Devices. 5th Annual Lillehei Symposium, April 2004.
26. John R. Current status of left ventricular assist device therapy for heart failure: Design of medical devices. University of Minnesota, April 2004.
27. John R. Cardiac Surgery at the University of Minnesota. ATS Valve Course, October 2004.
28. John R. Cardiac Surgery: Valvular diseases. Advanced Cardiac Physiology and Anatomy Course, University of Minnesota, January 2005.
29. John R. Left Ventricular Assist Devices. Rural Physician Associate Program. Crosby, MN, February 2005.
30. John R. Genes And Stem Cells: Can they mend a broken heart. 6th Annual Cutting edge Conference, New Frontiers in Transplantation. Minneapolis, MN, March 2005.
Top of page
ABSTRACTS:
1. John R, Hertz M, Savik K, Cahill B, Fox J, Reinsmoen N, Bolman RM: Multivariate analysis of risk factors for obliterative bronchiolitis in lung allograft recipients. Journal of Heart and Lung Transplantation 1994; 13: S53.
2. John R, Bolman RM, Kshettry V, Savik K, Hertz MI: Does age > 50 years have adverse outcomes on lung allograft recipients. Journal of Heart and Lung Transplantation 1995; 19: S197.
3. John R, Burke E, Mancini D, et al. Intravenous immunoglobulin versus cyclophosphamide and plasmapheresis for reduction of anti-HLA antibodies in highly sensitized patients awaiting cardiac transplantation. Journal of Heart and Lung Transplantation 1998;52.
4. Itescu S, Burke E, John R, et al. Improved outcome in highly sensitized cardiac transplant recipients using intravenous cyclophosphamide. Journal of Heart and Lung Transplantation 1998:50.
5. Ankersmit J, Shah S, Spanier T, Kwiatkowski P, John R, et al. Defective T cell activation in vitro and in vivo following exposure to left ventricular assist devices. Journal of Heart and Lung Transplantation 1998.
6. Chen JM, Cullinane S, Spanier TB, Artrip J, John R, et al. Arginine vasopressin (AVP) is deficient in hemodynamically unstable organ donors and AVP replacement increases blood pressure and reduces pressor requirements. Journal of Heart and Lung Transplantation 1998.
7. John R, Choudhri A, Weinberg A, et al. Defining high risk CABG patients at risk for stroke: a case for MIDCABG. Circulation, 1998, Supplement 1; I-98.
8. John R, Suratwalla S, Mancini D, Weinberg A, Itescu S, R Druzin, Rose EA, Edwards NM. Long-term survival (> 10 years) after cardiac transplantation in the cyclosporine era. Circulation, 1998, Supplement 1; I-184.
9. John R, Lietz K, Burke E, et al. Successful management of highly sensitized patients awaiting cardiac transplantation using intravenous immunoglobulin. Circulation, 1998, Supplement 1; I-691.
10. John R, Kwiatkowski P, Artrip JH, et al. Interactions between human natural killer cells and B cells cause augmentation of IgG humoral responses. Circulation, 1998, Supplement 1;I-830.
11. Chen JM, Culinane S, Spanier TB, Artrip JH, John R, et al. Physiologic low dose arginine vasopressin (AVP) "replacement" therapy salvages hemodynamically unstable organ donors. Circulation, 1998, Supplement 1;I-752.
12. Ankersmit J, Tuglea S, Spanier T, Tsao L, John R, et al. LVAD implantation is associated with increased susceptibility to activation induced cell death and defects in cell-mediated immunity. Circulation, 1998, Supplement 1;I-830.
13. Chen J, Rajasinghe H, Sinha P, Suratwala S, McCue J, Hauff H, John R, et al. Do donor characteristics really matter? Analysis of 161 consecutive heart donors. Journal of Heart and Lung Transplantation 2000:20:100
14. Kocher A, Schuster M, Lietz K, John R, et al. Female cardiac transplant recipients demonstrate increased prevalence of autoimmunity and greater risk for alloreactivity. Circulation, 2000, 12 ; Supplement II;II-817.
15. Ma N, Szabolcs M, John R, Weinberg A, Itescu S, Edwards N. Prevention of accelerated rejection and prolonged survival in sensitized rats with cyclophosphamide therapy. Journal of Heart and Lung Transplantation 200:20:233.
16. John R, Lietz K, Burke E, Schuster M, et al. Intravenous immunoglobulin therapy in highly sensitized cardiac allograft recipients facilitates transplantation across donor specific IgG positive cross matches.Journal of Heart and Lung Transplantation 2001:20;213.
17. John R, Lietz K, Schuster M, Mancini D, et al. Older age is associated with reduced alloreactivity and graft rejection after cardiac transplantation. Journal of Heart and Lung Transplantation 2001:20;212.
18. Schuster M, Kocher A, John R, et al. Allosensitization following left ventricular assist device (LVAD) implantation is dependent on CD40-CD40 ligand interactions. Journal of Heart and Lung Transplantation 2001:20;211.
19. Chen J, Sinha P, Rajasinghe H, John R, Mancini D, Edwards N. The diminishing impact of pretransplant pulmonary hypertension on perioperative mortality after cardiac transplantation. Journal of Heart and Lung Transplantation 2001:20;235.
20. John R, Lietz K, Burke E, Schuster M, Mancini D, Edwards N, Itescu S. Outcomes of highly sensitized LVAD recipients transplanted across positive IgG cross matches. Circulation 2001;104: Supplement II;II-757.
21. Kavarana M, John R, Sinha P, Edwards N. Mechanical support for the failing cardiac allograft. Circulation 2001;104: Supplement II;II-759.
22. Ma N, John R, Szabolcs M, Weinberg A, Itescu S, Edwards N. Successful outcome of cardiac transplantation in sensitized rodents using immunosuppressive regimens prior to transplantation. Circulation, 2001;104: Supplement II;II-394.
23. Kukuy E, John R, Szabolcs M, Ma N, Schuster M, Cannon P, Fairlie D, Edwards N. Phospholipase A2 inhibitor attenuates Nox production and myocardial damage in the cardiac allograft. Journal of Heart and Lung Transplantation 2002;21:133.
24. A Kocher, M Schuster, R John, M Szabolcs, S Itescu: Sustained Regeneration of Endogenous Cardiomyocytes Following Induction of Large Vessels by Human Bone Marrow Angioblasts, Circulation 2002;106:11-64.
25. M Schuster, A Kocher, R John, S Itescu: Stromal Derived Growth Factor (SDF)-1 Augments Myocardial Neovascularization and Cardiomyocyte Regeneration Induced by Human Bone Marrow Angioblasts, Circulation 2002;106:11-64.
26. Dang N, Topkara V, John R, Lee B, Oz M, Naka Y. Early left ventricular assist device transplantation improves bridge to transplant rate following postcardiotomy cardiogenic shock. ASAIO 2004.
Top of page
Return to: Medical School : Academic Health Center : myU : U of M Home
